Schedule 13G ownership disclosure

TELIX PHARMACEUTICALS LTD

Ordinary Shares · CUSIP: 87961M105

Event date: 2024-11-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Kluge Andreas

    Shares: 22,675,000 · Class: 6.78%

  • Gnosis Verwaltungsgesellschaft m.b.H.

    Shares: 22,675,000 · Class: 6.78%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-004495
Form type
SCHEDULE 13G
Filer
Kluge Andreas
CIK
CIK 2037921
Filed
Feb 14, 2025
Reporting period
Nov 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub